About Veterinary Pimobendan

Pimobendan is used in drugs marketed by 2 different companies: Boehringer Lngelheim Animal Health Usa Inc, Cronus Pharma Specialities India Private Ltd.

Other drugs containing Pimobendan are: Vetmedin ca1 , Vetmedin , Pimomedin , Vetmedin solution .

Veterinary Pimobendan Patents

Given below is the list of patents protecting Pimobendan, along with the drug name that holds that patent and the company owning that drug.

Drug Used In	Drug Patent Number	Drug Patent Expiry	Drug Owner
Explore Patent Insights
Vetmedin CA1	US8846679	23 Jun, 2027	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin CA1	US8980894	12 Apr, 2026	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin CA1	US10537588	23 Mar, 2025	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin CA1	US11413285	23 Mar, 2025	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin CA1	US8859554	04 Mar, 2025	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin Solution	US9463199	27 Apr, 2029	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin Solution	US9889148	23 Mar, 2025	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.
Vetmedin	US8859554	04 Mar, 2025	BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC.

Pimobendan Petitions

Details of Pimobendan's suitability petitions are listed below.

Petitioner	Action	Date of Action	Description
Unlock Full Petitions Data
Norbrook Laboratories Limited	Approved	14 Dec, 2018	The proposed change is for an oral solution ; the RLNAD is approved as chewable tablets in 1.25 mg, 2.5 mg, 5 mg, and 10 mg tablet strengths.
Felix Pharmaceuticals Pvt. Ltd.	Approved	13 Jun, 2018	The proposed change is from a compressed tablet to a soft chewable tablet.
Noble Pharma, LLC	Approved
Piedmont Animal Health	Approved
Lachman Consultant Service, Inc.	Approved